Drug Shortage Report for LYSODREN
Report ID | 57276 |
Drug Identification Number | 00463221 |
Brand name | LYSODREN |
Common or Proper name | Mitotane |
Company Name | HRA PHARMA RARE DISEASES |
Market Status | MARKETED |
Active Ingredient(s) | MITOTANE |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 1 BTL x 100 |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-12-28 |
Actual start date | |
Estimated end date | 2018-12-28 |
Actual end date | 2019-01-02 |
Shortage status | Resolved |
Updated date | 2019-01-04 |
Company comments | Orders are being allocated. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 200 AVENUE DE PARIS CHATILLON, HAUTS-DE-SEINE FRANCE 92320 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2019-01-04 | English | Compare |
v9 | 2018-12-29 | English | Compare |
v8 | 2018-10-30 | French | Compare |
v7 | 2018-10-30 | English | Compare |
v6 | 2018-10-19 | French | Compare |
v5 | 2018-10-19 | English | Compare |
v4 | 2018-08-17 | French | Compare |
v3 | 2018-08-17 | English | Compare |
v2 | 2018-08-01 | French | Compare |
v1 | 2018-08-01 | English | Compare |
Showing 1 to 10 of 10